OM PHARMA expands its manufacturing capacities in Switzerland
January 25th, 2008

The latest batches of Broncho-Vaxom® and Uro-Vaxom® capsules have been produced this month in OM PHARMA’s newly completed industrial premises at its headquarters in Meyrin/Geneva.

OM PHARMA expanded and qualified within 9 months new high-performance equipments for ingredient mixing, powder transfer and capsule filling.

With this investment of CHF 1.5 million, OM PHARMA has increased its capacity for pharma operations of up to 650 million capsules per year in order to meet its own growing market needs and numerous partners’ requirements.

Together with its subsidiary in Portugal, OM PHARMA is also able to subcontract biotech and pharma manufacturing capacities to third parties.

Top of the page